Risk Factors for Pediatric Human Immunodeficiency Virus-Related Malignancy

JAMA

Volumn 289, Issue 18, 2003, Pages 2393-2399

  Pollock, Brad H ^a,b   Jenson, Hal B ^c   Leach, Charles T ^b   McClain, Kenneth L ^d   Hutchison, Robert E ^e   Garzarella, Linda ^f   Joshi, Vijay V ^g   Parmley, Richard T ^h   Murphy, Sharon B ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g HARTFORD HOSPITAL   (United States)

^h Greenville Hospital System Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE; ANTIVIRUS AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY BURDEN; CANCER EPIDEMIOLOGY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEMOGRAPHY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HEPATOBLASTOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFECTION; INFECTION COMPLICATION; LEIOMYOSARCOMA; LYMPHOCYTE COUNT; MALE; MULTICENTER STUDY; NEURILEMOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS LOAD; B CELL LYMPHOMA; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; IMMUNOLOGY; INFANT; NEOPLASM; PRESCHOOL CHILD; REGRESSION ANALYSIS; VIROLOGY; VIRUS INFECTION;

ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATOBLASTOMA; HERPESVIRUS 6, HUMAN; HIV INFECTIONS; HUMANS; INFANT; LEIOMYOSARCOMA; LYMPHOMA, AIDS-RELATED; MALE; NEOPLASMS; NEURILEMMOMA; REGRESSION ANALYSIS; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; VIRAL LOAD;

EID: 0038316598     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.18.2393     Document Type: Article

References (22)

1. Biggar RJ, Frisch M, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Risk of cancer in children with AIDS. JAMA. 2000;284:205-209.
2. Rabkin CS, Hilgartner MW, Hedberg KW, et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA. 1992;267:1090-1094.
3. Ragni MV, Belle SH, Jaffe RA, et al. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood. 1993;81:1889-1897.
4. Kawakami K, Takezaki T, Nakazono S, et al. Acute childhood leukemia in a patient with hemophilia: first report in Japan. Acta Paediatr Jpn. 1994;36:91-94.
5. Caselli D, Klersy C, de Martino M, et al. Human immunodeficiency virus-related cancer in children: incidence and treatment outcome-report of the Italian Register. J Clin Oncol. 2000;18:3854-3861.
6. Pluda JM, Yarchoan R, Jaffe ES, et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med. 1990;113:276-282.
7. Jenson H, McIntosh K, Pitt J, et al. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis. 1999;179:1395-1404.
8. Project N-HsLPC. National Cancer Institute study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982;49:2112-2135.
9. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med. 1995;332:12-18.
10. Demmler GJ, Buffone GJ, Schimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis. 1988;158:1177-1184.
11. Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives [letter]. Lancet. 1990;335:1598-1599.
12. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-491.
13. Jenson HB, Ench Y. Epstein-Barr virus. In: Rose NR, Hamilton RG, Derrick B, eds. Manual of Clinical Laboratory Immunology. 6th ed. Washington, DC: American Society for Microbiology; 2002:615-626.
14. Leach CT, Newton ER, McParlin S, Jenson HB. Human herpesvirus 6 infection of the female genital tract. J Infect Dis. 1994;169:1281-1283.
15. Leach CT, Pollock BH, McClain KL, Parmley RT, Murphy SB, Jenson HB. Human herpesvirus 6 and cytomegalovirus infections in children with human immunodeficiency virus infection and cancer. Pediatr Infect Dis J. 2002;21:125-132.
16. Jenson HB, Leach CT, McClain KL, et al. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma. 1997;27:303-314.
17. Mueller BU, Jenson H, McIntosh K, et al. HIV-associated malignancies in children. AIDS Patient Care STDS. 1999;13:527-533.
18. Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol. 1998;16:1729-1735.
19. McClain KL, Leach CT, Jenson HB, et al. Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J Acquir Immune Defic Syndr. 2000;23:152-159.
20. Van Baarle D, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis. 2002;186:405-409.
21. Olivero OA, Anderson LM, Diwan BA, et al. Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst. 1997;89:1602-1608.
22. Connor EM, Sperling RS, Gelber R, et al, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodefidency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.